Global Rice News

Food and Drug Administration Import Alerts: What You Need to Know

The Food and Drug Administration (FDA) has recently issued or modified several import alerts that affect various products from different countries. These import alerts serve to inform FDA field staff about products that may be in violation of FDA laws and regulations, allowing them to detain these products without physical examination upon entry into the United States.

Here are some of the import alerts that have been issued or modified in the past week:

1. Anesthetics from China
2. Antibiotics from India
3. Basmati rice from India and Pakistan
4. Candy from China
5. Cantaloupes from Mexico
6. Massagers from China
7. Medical devices from Pakistan
8. Milk thistle from Korea
9. Raw shrimp from India and Indonesia
10. Saffron from Afghanistan and Spain

Import alerts can cover products from specific countries or areas, manufacturers, or shippers. When a firm or product is listed on the “red list” of an import alert, it is subject to Detention Without Physical Examination (DWPE). On the other hand, if a firm or product is on the “green list,” it means they have met the exclusion criteria and are not subject to DWPE. Some import alerts may also include a “yellow list” that identifies firms, products, and/or countries under intensified surveillance due to the nature of the violations.

It is important to note that even if a product is subject to DWPE, it may still be imported into the U.S. if the importer can demonstrate that the shipment is in compliance with FDA laws and regulations.

If a product is detained without physical examination, the importer has the right to provide evidence to the FDA to challenge the violation. However, if sufficient evidence is not provided or deemed inadequate, the product will be refused entry into the U.S.

For more information on FDA import alerts and other related issues, please contact FDA consultant Domenic Veneziano at (202) 734-3939 or via email.

Source: [Source Article](https://www.strtrade.com)

Key Information:
– FDA has issued or modified import alerts for various products.
– Import alerts notify FDA field staff of potential violations.
– Products on the “red list” are subject to Detention Without Physical Examination (DWPE).
– “Green list” products have met exclusion criteria and are not subject to DWPE.
– Some import alerts include a “yellow list” for intensified surveillance.
– Products subject to DWPE may still be imported if compliance is demonstrated.
– Importers can provide evidence to challenge detention without physical examination.

Now, let’s incorporate the provided keywords and their respective links into the rewritten article:

Food and Drug Administration Import Alerts: What You Need to Know

The Food and Drug Administration (FDA) has recently issued or modified several import alerts that affect various products from different countries. These import alerts serve to inform FDA field staff about products that may be in violation of FDA laws and regulations, allowing them to detain these products without physical examination upon entry into the United States.

Here are some of the import alerts that have been issued or modified in the past week:

1. Anesthetics from China
2. Antibiotics from India
3. Basmati rice from India and Pakistan
4. Candy from China
5. Cantaloupes from Mexico
6. Massagers from China
7. Medical devices from Pakistan
8. Milk thistle from Korea
9. Raw shrimp from India and Indonesia
10. Saffron from Afghanistan and Spain

Import alerts can cover products from specific countries or areas, manufacturers, or shippers. When a firm or product is listed on the “red list” of an import alert, it is subject to Detention Without Physical Examination (DWPE). On the other hand, if a firm or product is on the “green list,” it means they have met the exclusion criteria and are not subject to DWPE. Some import alerts may also include a “yellow list” that identifies firms, products, and/or countries under intensified surveillance due to the nature of the violations.

It is important to note that even if a product is subject to DWPE, it may still be imported into the U.S. if the importer can demonstrate that the shipment is in compliance with FDA laws and regulations.

If a product is detained without physical examination, the importer has the right to provide evidence to the FDA to challenge the violation. However, if sufficient evidence is not provided or deemed inadequate, the product will be refused entry into the U.S.

For more information on FDA import alerts and other related issues, please contact FDA consultant Domenic Veneziano at (202) 734-3939 or via email.

Source: [**Source**](https://www.strtrade.com){:target=”_blank” rel=”nofollow”}

Key Information:
– FDA has issued or modified import alerts for various products.
– Import alerts notify FDA field staff of potential violations.
– Products on the “red list” are subject to Detention Without Physical Examination (DWPE).
– “Green list” products have met exclusion criteria and are not subject to DWPE.
– Some import alerts include a “yellow list” for intensified surveillance.
– Products subject to DWPE may still be imported if compliance is demonstrated.
– Importers can provide evidence to challenge detention without physical examination.

Feel free to add any additional formatting or improve the language to make it more engaging and appealing to the reader.